1. Market Research
  2. > Pharmaceutical Market Trends
  3. > Oman Pharmaceuticals and Healthcare Report Q1 2017

Oman Pharmaceuticals and Healthcare Report Q1 2017

  • November 2016
  • -
  • Business Monitor International
  • -
  • 71 pages

Includes 3 FREE quarterly updates


BMI View:

Oman’s evolving demographic and epidemiological profile will act as key drivers of growth within the country’s pharmaceuticals and healthcare markets over the coming years - shaping opportunities for multinational pharmaceutical companies. The rollout of a compulsory health insurance scheme, promotion of medical tourism and greater international collaboration will boost the private sector’s contribution to healthcare in Oman. Over the long term, however, the public sector will remain the dominant healthcare player as the rapidly growing demand for healthcare services necessitates high levels of government commitment.

Headline Expenditure Projections



- Pharmaceuticals: OMR244mn (USD634mn) in 2015 to OMR257mn (USD668mn) in 2016; +5.3% in local currency and US dollar terms. Forecast in line with Q416.

- Healthcare: OMR1.14bn (USD2.96bn) in 2015 to OMR1.19bn (USD3.08bn) in 2016; +3.9% in local currency and US dollar terms. Forecast in line with Q416.

Table Of Contents

Oman Pharmaceuticals and Healthcare Report Q1 2017
BMI Industry View 7
Table: Headline Pharmaceuticals and Healthcare Forecasts (Oman 2014-2020) 7
SWOT 9
Industry Forecast 12
Pharmaceutical Market Forecast 12
Table: Pharmaceutical Sales, Historical Data And Forecasts (Oman 2012-2020) 14
Healthcare Market Forecast 15
Table: Healthcare Expenditure Trends, Historical Data And Forecasts (Oman 2012-2020) 17
Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (Oman 2012-2020) 17
Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (Oman 2012-2020) 18
Prescription Drug Market Forecast 19
Table: Prescription Drug Market Indicators, Historical Data And Forecasts (Oman 2012-2020) 20
Patented Drug Market Forecast 21
Table: Patented Drug Market Indicators, Historical Data And Forecasts (Oman 2012-2020) 22
Generic Drug Market Forecast 23
Table: Generic Drug Market Indicators, Historical Data And Forecasts (Oman 2012-2020) 24
OTC Drug Market Forecast 25
Table: Over-The-Counter (OTC) Medicine Market Indicators, Historical Data And Forecasts (Oman 2012-2020) 26
Pharmaceutical Trade Forecast 27
Table: Pharmaceutical Trade Data And Forecasts (Oman 2014-2020) 28
Table: Pharmaceutical Trade Data And Forecasts local currency (Oman 2014-2020) 29
Industry Risk/Reward Index 30
Middle East And Africa Risk/Reward Index - Q1 2017 30
Oman Risk/Reward Index 38
Rewards 38
Risks 38
Regulatory Review 40
Intellectual Property Issues 40
Pricing Regime 41
Reimbursement Regime 42
Market Overview 43
Healthcare Sector 44
Table: Healthcare Personnel (Oman 2010-2015) 46
Table: Healthcare Activity (Oman 2010-2015) 46
Research and Development 46
Clinical Trials 47
Epidemiology 48
Competitive Landscape 51
Generic Drugmakers 53
Pharmaceutical Distribution 53
Company Profile 54
National Pharmaceutical Industries 54
Zynova/Oman Pharmaceutical Products Company 57
Demographic Forecast 60
Table: Population Headline Indicators (Oman 1990-2025) 61
Table: Key Population Ratios (Oman 1990-2025) 61
Table: Urban/Rural Population and Life Expectancy (Oman 1990-2025) 62
Table: Population By Age Group (Oman 1990-2025) 62
Table: Population By Age Group % (Oman 1990-2025) 63
Glossary 65
Methodology 67
Pharmaceutical Expenditure Forecast Model 67
Healthcare Expenditure Forecast Model 67
Notes On Methodology 68
Risk/Reward Index Methodology 69
Index Overview 70
Table: Pharmaceutical Risk/Reward Index Indicators 70
Indicator Weightings 71

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024

PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024

  • $ 10995
  • Industry report
  • September 2016
  • by Global Data

PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024 Summary Attention deficit hyperactivity disorder (ADHD) is characterized by excessive levels ...

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

  • $ 7000
  • Industry report
  • August 2016
  • by Frost & Sullivan

Emerging Business Models Drive Transformation The key objective of this research is to provide in-depth knowledge of the major global pharmaceutical CMO market segments—active pharmaceutical ingredients ...

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation

  • $ 6995
  • Industry report
  • November 2016
  • by GBI Research

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation Summary Asthma is a chronic condition affecting ...


ref:plp2016

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.